Pathogenetic mechanisms of amyotrophic lateral sclerosis

被引:0
|
作者
Ilzecka, Joanna [1 ]
机构
[1] Uniwersytet Medyczny Lublinie, Samodzielna Pracownia Rehabilitacji Neurologiczne, Ul Chodzki 6, PL-20093 Lublin, Poland
来源
AKTUALNOSCI NEUROLOGICZNE | 2012年 / 12卷 / 04期
关键词
amyotrophic lateral sclerosis; pathogenetic mechanisms; oxidative stress; glutamate-related toxicity; mitochondrial dysfunction; aggregation of proteins; genetic factors;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease, resulting in a damage of motor neurons. Pathogenesis of ALS is most probably multifactorial, complex and not entirely elucidated. It may involve such mechanisms as oxidative stress, toxicity of glutamic acid, dysfunction of the mitochondria, stress of endoplasmic reticulum, aggregation of proteins, dysfunction of the cytoskeleton, disturbed axonal transport, role of glial cells, neuroinflammatory process, lactic acid dyscrasia, and genetic factors. An important cause of oxidative stress in ALS are mutations of superoxide dismutase 1 (SOD1) gene leading to altered activity of the enzyme and its enhanced toxicity. Abnormal SOD1 participates in inflammatory response of activated astrocytes and microglia in the spinal cord of ALS patients. Mechanisms of oxidative stress and glutamate toxicity are coupled together. Death of motor neurons occurs as a result if activation of caspases and apoptosis, while mitochondrial dysfunction merely participates in the process. Pathomorphological alterations within the endoplasmic reticulum are present already at an early phase of the disease and indicate that stress within this structure plays an important role in the ALS-related process of neurodegeneration. Another interesting feature of ALS are alterations of cytoskeleton, concerning mainly neurofilaments. According to the hypothesis of lactic acid dyscrasia, dysregulation of myoneuronal lactic acid channel results in cellular stress, toxicity and progressive degeneration. An important role in the pathogenesis of ALS may be also played by genetic mutations of proteins other than SOD1.
引用
收藏
页码:222 / 235
页数:14
相关论文
共 50 条
  • [41] AMYOTROPHIC LATERAL SCLEROSIS
    ROLLER, NW
    GARFUNKEL, A
    NICHOLS, C
    SHIP, II
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1974, 37 (01): : 46 - 52
  • [42] Amyotrophic lateral sclerosis
    Vandenberghe, W
    Brorson, JR
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15): : 1131 - 1132
  • [43] Amyotrophic lateral sclerosis
    Mitchell, J. D.
    Borasio, G. D.
    LANCET, 2007, 369 (9578): : 2031 - 2041
  • [44] MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis
    Gagliardi, Delia
    Comi, Giacomo P.
    Bresolin, Nereo
    Corti, Stefania
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (03) : 1647 - 1656
  • [45] Amyotrophic lateral sclerosis: distinct mechanisms for disease initiation and progression
    不详
    NEUROSCIENTIST, 2006, 12 (05): : 374 - 374
  • [46] Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies
    Yang, Xiaoming
    Ji, Yanan
    Wang, Wei
    Zhang, Lilei
    Chen, Zehao
    Yu, Miaomei
    Shen, Yuntian
    Ding, Fei
    Gu, Xiaosong
    Sun, Hualin
    ANTIOXIDANTS, 2021, 10 (07)
  • [47] EXCITOTOXIC MECHANISMS IN THE PATHOGENESIS OF AMYOTROPHIC-LATERAL-SCLEROSIS - A DISCUSSION
    KATO, AC
    PATHOGENESIS AND THERAPY OF AMYOTROPHIC LATERAL SCLEROSIS, 1995, 68 : 21 - 27
  • [48] Amyotrophic lateral sclerosis: from pathological mechanisms to patient care
    G. Scarlato
    Journal of Neurology, 1997, 244 : S1 - S2
  • [49] Amyotrophic Lateral Sclerosis
    不详
    US PHARMACIST, 2022, 47 (01) : 15 - 16
  • [50] AMYOTROPHIC LATERAL SCLEROSIS
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1962, (5300): : 317 - +